These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7878855)

  • 1. High incidence of posttransplant hepatitis and chronic rejection associated with hepatitis C virus infection in liver transplant recipients.
    Loinaz C; Lumbreras C; González-Pinto I; Colina F; Gómez R; Fuertes A; Alvarado A; García I; Noriega AR; Moreno E
    Transplant Proc; 1995 Feb; 27(1):1217-8. PubMed ID: 7878855
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
    Mueller AR; Platz KP; Bechstein WO; Blumhardt G; Lobeck H; Hop U; Neuhaus P
    Transplant Proc; 1994 Dec; 26(6):3637-9. PubMed ID: 7527984
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepatitis C virus infection on short-term outcomes in renal transplantation.
    Broumand B; Hakemi MS; Sabet MS
    Exp Clin Transplant; 2004 Dec; 2(2):242-5. PubMed ID: 15859935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract]   [Full Text] [Related]  

  • 8. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I; Ulloa E; Colina F; Abradelo M; Jiménez C; Gimeno A; Meneu JC; Lumbreras C; Solís-Herruzo JA; Moreno E
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection.
    Neff GW; Shire N; Ruiz P; O'Brien C; Garcia M; Dela Garza J; Rudich SR; Reddy KR
    Transplant Proc; 2005 Dec; 37(10):4397-402. PubMed ID: 16387130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
    Lawal A; Ghobrial R; Te H; Artinian L; Eastwood D; Schiano TD
    Transplant Proc; 2007 Dec; 39(10):3261-5. PubMed ID: 18089367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of liver and gastrointestinal transplantation at the University of Miami.
    Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG
    Clin Transpl; 1996; ():187-201. PubMed ID: 9286568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P
    Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
    Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL
    Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
    Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV+ donors: should they be used for organ transplantation?
    Aswad S; Obispo E; Mendez RG; Mendez R
    Transplant Proc; 1993 Dec; 25(6):3072-4. PubMed ID: 8266457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.